This study is in progress, not accepting new patients
Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).
Summary
- Eligibility
- for people ages 18-100 (full criteria)
- Location
- at Stanford, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Amgen
- Links
- AmgenTrials clinical trials website
- ID
- NCT04303780
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- About 345 people participating
- Last Updated